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The zoonotic potential to cause human and/or animal infections among multidrug-resistant
extraintestinal pathogenic Escherichia coli from avian origin was investigated. Twenty-seven
extraintestinal  pathogenic E. coli isolates containing the increased survival gene (iss) were
obtained  from the livers of healthy and diseased poultry carcasses at two slaughterhouses
in  Salvador, northeastern Brazil. The antimicrobial resistance-susceptibility proﬁles were
conducted  with antibiotics of avian and/or human use by the standardized disc-diffusion
method.  Antimicrobial resistance was higher for levoﬂoxacin (51.8%), amoxicillin/clavulanic
acid  (70.4%), ampicillin (81.5%), cefalotin (88.8%), tetracycline (100%) and streptomycin
(100%).  The minimum inhibitory concentrations above the resistance breakpoints of doxy-
cycline,  neomycin, oxytetracycline and enroﬂoxacin reached, respectively, 88.0%, 100%, 75%
and 91.7% of the isolates. Strains with high and low antimicrobial resistance were i.p. admin-
istered to Swiss mice, and histopathological examination was carried out seven days after
infection.  Resistance to goat and human serum complement was also evaluated. The results
show  that Swiss mice challenged with strain 2B (resistant to 11 antimicrobials) provoked a
severe degeneration of hepatocytes besides lymphocytic inﬁltration in the liver, whereas
the  spleen showed areas of degeneration of the white and red pulp. Conversely, the spleen
and  liver of mice challenged with strain 4A (resistant to two antimicrobials) were morpho-
logically  preserved. In addition, complement resistance to goat and human serum was highfor  strain 2B and low for s
esis  can be correlated in e
healthy  poultry carcasses
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Table 1 – ExPEC strains obtained from the liver of poultry
carcasses.
E. coli Macroscopic aspect Presence of
gene issa
Presence of
gene  stxb
4A No alteration + −
5A No alteration + −
36A No alteration + −
41A No alteration + −
43A No alteration + +
44A No alteration + −
2B No alteration + −
5B No alteration + −
37B No alteration + −
38B No alteration + +
39B No alteration + −
42B No alteration + −
15C No alteration + −
21C No alteration + −
42C No alteration + −
32 No alteration + −
35 No alteration + −
46 No alteration + +
24A Salmonella septicemia + −
30C Salmonella septicemia + −
31C Salmonella septicemia + −
48A Ascitis + −
48B Ascitis + −
52B Cachexy + −
54B Cachexy + −
60A Colibacillosis + −
55B Colibacillosis + −
a Increased serum survival gene.b r a z j i n f e c t d i
ntroduction
he spread of multidrug resistance among avian Escherichia coli
s usually attributed to the selective pressure exerted by the
ntimicrobials included in broiler feed for the past 60 years.1
ohnson et al.2 reinforced this suspicion since antibiotic-
esistant and antibiotic-susceptible E. coli isolates from
etail  poultry products had similar phylogenetic background,
nd  otherwise emerged from the same source population.
egarding antimicrobial exposure in poultry production, mul-
idrug  resistance among extraintestinal pathogenic E. coli
ExPEC)  allied to community acquired infections is increasing
n  prevalence in many  parts of the globe.3 The indiscriminate
se of antimicrobials is high in developing countries, where
uman  antibiotics are often accessible for non-therapeutic
ses in healthy animals.4 Therefore, colonization of asymp-
omatic  poultry by multidrug resistant ExPEC augments the
robability  of resistance gene acquisition by human strains
hrough  the food-chain.
Avian  pathogenic E. coli (APEC) is commonly reported as
n  ExPEC pathotype, but its genotype is not clearly deﬁned.
ccording to Kwon et al.5 at least ﬁve virulence genes are
resent  in APEC, many  of them found in plasmid pTJ100.6
owever, the increased survival gene (iss) has been iden-
iﬁed  as a virulence marker to distinguish between avian
nd  human ExPEC.7 This gene exerts anti-complement resis-
ance  and has been found in conserved regions of ColV
nd  ColBM plasmids,8,9 which are often identiﬁed in APEc
trains.6,10 Recent ﬁndings also suggest that APEC and human
eonatal meningitis E. coli (NMEC) are subpathotypes from
xPEC  involved in pathogenesis of both avian and human
nfections.11 Therefore, hybrid plasmids (ColV- and ColBM-
ssociated plasmids) harboring a number of distinct virulence
enes  and MDR-encoding islands can also be present in ExPEC
solates.11 Consequently, it is now clear that selected high-
irulent  and multidrug resistant ExPEC strains of avian origin
epresent  subpathotypes of great danger to human public
ealth.
Brazil  has ranked ﬁrst in the world in exports of poultry
eat since 2004.12 Typical selections of poultry in Brazilian
laughterhouses take into account macroscopic alterations
hat  can result in discarding carcasses.13 However, sub-clinical
ymptoms are not always perceived and often do not show
 clue of the presence of pathogenic microorganisms. Thus,
he  risk of virulence and drug resistance gene transmission
etween avian E. coli obtained trough the food-chain and
ntestinal  commensal E. coli is increasing. The goal of the
resent  study was  to investigate the pathogenesis to mam-
alian  hosts of selected multidrug resistant ExPEC strains
btained from healthy poultry carcasses in Salvador, Brazil.
aterial  and  methods
xPEC  strainsxtraintestinal pathogenic E. coli strains were obtained from
he  livers of poultry carcasses with (n = 9) or without (n = 18)
acroscopic alterations at two slaughterhouses in Salvador,b Shiga-like toxin gene.
capital of the state of Bahia, northeast Brazil (Table 1).
Carcasses without macroscopic alterations were  considered
healthy and approved for human consumption. The organs
were  collected under sterile conditions. All bacterial strains
were  identiﬁed through biochemical tests, and the presence of
the  iss gene was determined according to the method reported
in  a previous study.14 The isolates were maintained in tubes
containing brain heart infusion agar at 8 ◦C until use.
Antimicrobial  resistance-susceptibility  proﬁle  of  ExPEC
strains
The resistance-susceptibility proﬁles to antimicrobials of
avian  or human use were  determined by the standard disc-
diffusion  method, following the recommendations of the
Clinical  and Laboratory Standards Institute (formally, National
Committee  for Clinical Laboratory Standards).15 Brieﬂy, ﬁlter
paper  discs 5 mm in diameter impregnated with antibiotics
(Cecon) were added to cultures in Petri dishes (0.5 on the
McFarland scale, corresponding to 108 cells/mL) containing
Mueller–Hinton agar (Oxoid). After 24 h incubation at 35 ◦C, the
diameter  of the inhibition zone was measured with a caliper.
All  tests were carried out in duplicate against 13 antimicro-
bials  and the results were interpreted as sensitive, moderately
sensitive or resistant. The breakpoints for resistance were
those  recommended by the CLSI. The overall resistance rate
was  calculated as the number of non-susceptible isolates
56  b r a z j i n f e c t d i s . 2
Table 2 – Antimicrobials authorized by Brazilian
authorities used as growth promoters in broiler feed.
Antimicrobial class Antimicrobials Dosage (g/ton)
Oligosaccharide Avilamicin 2.5–10
Peptide Bacitracin methylene
disalicylate
4–55
Peptide Zinc bacitracin 4–55
Benzene derivative Chlorhexidine 10–20
Macrolide Spiramycin 5
Peptide Enramycin 3–10
Phosphoglycolipids Flavomycin 1–2
Lincosamide Lincomycin 2.2–4.4
Peptide Colistin sulfate 2–10
Streptogramin Virginiamycin 5.5–16.5
Quinolone Clorohidroxiquinolin 15–30
Macrolide Tylosin
tartrate/phosphate
4–55
were  resistant to levoﬂoxacin (51.8%), amoxicillin/clavulanic
acid (70.4%), ampicillin (81.5%), cefalotin (88.8%), tetracyclineSource: Brazilian Ministery of Agriculture.
divided by the total number of isolates. Multidrug resistance
was  determined when bacterial isolates were resistant to four
antimicrobials  of at least three different classes. The isolates
obtained  from a single sample with an identical antibiotic
resistance/sensitivity proﬁle were treated as a single strain.
In  this case, bacterial replicates were not conducted.
Minimum  inhibitory  concentration  of  typical
antimicrobials  used  on  Brazilian  farms
The minimum inhibitory concentration (MIC) of antimi-
crobials commonly used on Brazilian farms (doxycycline,
neomycin, oxytetracycline and enroﬂoxacin) was  measured
through  the broth dilution method in concentrations ranging
from  1.9 to 1000 g/mL.16 The MIC  was  the lowest concen-
tration that caused visible inhibition of growth, while the
minimum  bactericidal concentration (MBC) was the lowest
concentration resulting in no growth after the incubation
period of 24 h at 37 ◦C. All assays were performed in duplicate
with  25 ExPEC strains resistant to 4–11 antimicrobials through
the  disc-diffusion method. A list of antimicrobials authorized
by  the Brazilian government to be included in broiler feed is
shown  in Table 2.
Complement  resistance  assay
The complement resistance test was  carried out with selected
ExPEC  strains obtained from healthy carcasses, and with dis-
tinct  drug resistance proﬁle, following the method adapted
from  Samuelsen et al.17 Samples of blood were obtained from
goats  and a healthy human volunteer under sterile condi-
tions  and allowed to coagulate. The blood was  centrifuged
(7000 rpm/5 min) and blood serum was  separated into a new
tube.  Brieﬂy, 190 L of the serum plus 10 L of E. coli strains
(107 cells/mL) were  cultured together in wells of sterile Elisa
plates,  and incubated at 37 ◦C for 180 min. Then, aliquots of
10  L were  sampled at times 0, 60, 120 and 180 min, and added
to  Petri dishes containing MacConkey agar for enumeration
of  the colony forming units. The absence of speciﬁc antibod- 0 1 3;1 7(1):54–61
ies  for the ExPEC strains used in this study was  conﬁrmed by
in  vitro agglutination tests.
Animals
Adult male Swiss mice weighing approximately 35 g, obtained
from  Keizo-Azami Immunopathology Laboratory (LIKA/UFPE),
were  used. The animals were kept in an animal house with free
access  to water and commercial sterile diet (Purina, Paulínia,
SP,  Brazil). The mice were handled according to established
experimental procedures.
Experimental  infection  with  selected  ExPEC  strains
The mice were separated into three groups (n = 5) and chal-
lenged  by the intraperitoneal (i.p.) route with 0.2 mL  of
bacterial  suspensions containing 106 CFU/mL. Experimental
infections were  carried out with strains 4A, 41A and 2B. Clin-
ical  symptoms such as prostration, weight loss and mortality
were  observed daily for seven days post-infection. Survivors
were  sacriﬁced under anesthesia with Halothane (Halocarbon
Laboratories, USA). Sections of the liver were  submitted to
enumeration  of colony forming units (CFU/g) and histological
examination.
Enumeration  of  colony  forming  units
The spleens and livers were dissected, weighed and macera-
ted  in PBS (1:10 or 1:100, w/v) under sterile conditions. Serial
decimal  dilutions were made and 0.1 mL  aliquots were plated
onto  MacConkey agar (Oxoid). The colonies were counted after
incubation  at 37 ◦C for 24 h and the results expressed as CFU/g
of  organ.
Histological  examination
Tissues were ﬁxed in 10% formaldehyde and processed for
parafﬁn  embedding. The sections (5 m)  were  stained with
hematoxylin–eosin and the slides were  coded and examined
by  a single pathologist, who was unaware of the experimental
conditions of each group.
Statistical  analyses
The statistical signiﬁcance of data was assessed by analysis
of  variance (ANOVA), followed by Student’s t-test. The level of
signiﬁcance  was determined as p < 0.05.
Results
The antimicrobial resistance-susceptibility proﬁles of 27
extraintestinal pathogenic E. coli strains from carcasses of
healthy  and diseased poultry are shown in Table 3. The
majority of ExPEC were  resistant to at least four antibi-
otics from different classes. The most prevalent phenotypes(100%)  and streptomycin (100%). The overall multidrug resis-
tance  varied from 4 to 11 antimicrobials and reached 92.6% of
b r a z j i n f e c t d i s . 2 0 1 3;1  7(1):54–61  57
Table 3 – Resistance-susceptibility proﬁles of ExPEC strains to antimicrobials of avian or human use in Brazil.
Antimicrobial class Antimicrobials Disc
content
(g)
Use:
Avian  (A)
Human (H)
Resistance
breakpoint
(mm)
Healthy
carcasse
Diseased
carcasse
Overall
Resistance
%b
Resistant
strains
S %a I % R % S % I % R %
Penicillin Ampicillin 10 A/H ≤13 11.2 5.5 83.3 11.3 11 77.7 81.5 44A, 15C, 48B,
36A,  43A, 5B,
21C,  42C, 35,
31C,  52B, 55B,
5A,  24A, 54B,
6  60A, 38B, 37B,
3  39B, 46, 41A,
2  2B
Aminoglycoside Amikacin 30 A/H ≤14 72.4 11 16.6 100 0 0 1.1 36A, 42B, 2B
Gentamicin 10 A/H ≤12 61.3 11 27.7 56.6 0 44.4 33.3 32, 48B, 52B,
55B,  42B, 54B,
37B,  41A, 2B
Streptomycin 10 H ≤11 0 0 100 0 0 100 100 4A, 48A, 32,
44A,  15C, 30C,
48B,  36A, 43A,
5B,  21C, 42C,
35,  31C, 52B,
55B,  5A, 42B,
24A,  54B, 60A,
38B,  37B, 39B,
46,  41A, 2B
Fluoroquinolone Ciproﬂoxacin 5 A/H ≤15 22.3 27.750  67.7 0 33.3 44.4 30C, 43A, 35,
42B,  24A, 60A,
38B,  37B, 39B,
46,  41A, 2B
Levoﬂoxacin 5 H ≤13 27.9 11 61.1 55.6 11.1 33.3 51.8 15C, 30C, 43A,
42C,  35, 5A,
42B,  24A, 60A,
38B,  37B, 46,
41A,  2B
Phenicol Chloramphenicol 30 A/H ≤12 66.8 5.5 27.7 88.9 11.1 0 18.5 37B, 39B, 46,
41A,  2B
Cephalosporin Ceftazidim 30 H ≤14 56.7 27.716.6  66.7 22.2 11.1 14.8 54B, 39B, 46,
41A
Cefalotin 30 H ≤14 5.7 5.5 88.8 0 11.1 88.9 88.8 32, 44A, 15C,
30C,  48B, 36A,
43A,  5B, 21C,
42C,  31C, 52B,
55B,  5A, 42B,
24A,  54B, 60A,
38B,  37B, 39B,
46,  41A, 2B
Carbapenem Imipenem 10 H ≤13 100 0 0 100 0 0 0 -
Tetracycline Tetracycline 30 A/H ≤14 0 0 100 0 0 100 100 4A, 48A, 32,
44A,  15C, 30C,
48B,  36A, 43A,
5B,  21C, 42C,
35,  31C, 52B,
55B,  5A, 42B,
24A,  54B, 60A,
38B,  37B, 39B,
46,  41A, 2B
Monobactam Aztreonam 30 H ≤15 33.8 22.244  44.5 44.4 11.1 33.3 5B, 21C, 31C,
5A,  54B, 38B,
9B,  46, 41A,
2B
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Table 3 – (Continued )
Antimicrobial class Antimicrobials Disc
content
(g)
Use:
Avian (A)
Human (H)
Resistance
breakpoint
(mm)
Healthy
carcasse
Diseased
carcasse
Overall
Resistance
%b
Resistant
strains
S %a I % R  % S % I % R %
Beta-lactam/beta-
lactamase
inhibitor
Amoxycillin/
clavulanic acid
20/10 H ≤13 22.3 5.5 72.2 33.4 0 66.6 70.4 44A, 36A, 5B,
21C,  42C, 35,
31C,  52B, 55B,
5A,  24A, 54B,
60A,  38B, 37B,
39B,  46, 41A,
2B
r res
e isola Percentage of E. coli strains sensitive (S), intermediary sensitive (I) o
b The overall resistance rate is given by the number of non-susceptibl
tests.
E. coli strains. In addition, 40.7% were simultaneously resistant
to  streptomycin, levoﬂoxacin, ciproﬂoxacin and tetracycline.
The  proportion of highly multidrug resistant strains (8–11
antimicrobials) reached 22.2%. Conversely, the aminoglyco-
side  amikacin of avian and human use were very effective
against 89.9% of ExPEC. The MIC  and MBC  of typical antimi-
crobials  used in Brazilian farms were determined for those
ExPEC  strains resistant to at least 4 antimicrobials. The level
of  resistance against doxycycline, neomycin, enroﬂoxacin and
oxytetracycline  reached, respectively, 88.0%, 100%, 75% and
91.7%  of the strains (Table 4).
Table 4 – Resistance of multidrug resistant ExPEC strains from p
Brazilian farms.
Strain 
Doxycycline Neomy
MIC MBC MIC 
4A 125 – >1000 
48A 31.2 – >1000– 
32 >1000 – 500 
44A 62.5 500 >1000 
15C 62.5 1000 >1000 
30C 1.9 250 500 
48B 125 125 125 
36A 1.9 500 250 
43A 62.5 500 62.5 
5B 62.5 500 >1000 
21C 125 500 500 
42C 31.2 – 125 
35 125 250 500 
31C 125 500 250 
52B 31.2 – 500 
55B 62.5 1000 >1000 
24A 62.5 250 >1000 
54B 62.5 250 >1000 
60A 62.5 500 >1000 
38B 125 125 >1000 
37B 62.5 125 >1000 
39B 15.6 62.5 500 
46 62.5 125 500 
41A 62.5 62.5 >1000 
2B 125 125 125 
Resistance breakpoint ≥16 ≥32 istant (R) out of the total of isolates.
ates divided by the total number of isolates submitted to antibiogram
The complement resistance to goat serum was  high for
strains  2B and 46 and low for strains 4A and 41A, whereas
resistance to human serum was  high for strains 32, 46 and
2B  and low for strains 44 and 4A (Fig. 1). Experiments carried
out  with laboratory animals have shown that Swiss mice chal-
lenged  with strains 4A, 41A and 2B can survive seven days after
infection.  After this time, the bacterial load in the spleen and
3 3the  liver reached respectively: 3.74 × 10 and 8.54 × 10 CFU/g
for  strain 4A; 4.8 × 102 and 1.56 × 103 CFU/g for strain 41A,
and 4.0 × 101 and 1.2 × 104 CFU/g for strain 2B. However,
strain 2B provoked severe degeneration of hepatocytes besides
oultry carcasses to antimicrobials commonly used in
Antimicrobials (g/mL)
cin Enroﬂoxacin Oxytetracycline
MBC MIC MBC MIC MBC
– 1.9 31.2 >1000 –
– 1.9 250 >1000 –
500 62.5 1000 250 250
– 15.6 250 >1000 –
– 62.5 – 500 –
500 1.9 1.9 1.9 500
125 1.9 62.5 >1000 –
500 1.9 500 >1000 –
250 31.2 250 250 –
– 1.9 1000 250 –
1000 15.6 – 500 500
250 3.9 500 1000 –
500 31.2 – 62.5 500
250 15.6 1000 >1000 –
– 7.8 500 500 –
– 31.2 1000 250 –
– 125 – >1000 –
– >1000 – 7.8 7.8
– 15.6 1000 125 –
– 62.5 125 125 125
– 31.2 62.5 62.5 –
500 7.8 7.8 >1000 –
500 31.2 250 >1000 –
– NT NT NT NT
125 31.2 31.2 1000 –
≥2 ≥16
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ing  multidrug resistance and pathogenicity was  recentlyesistant avian ExPEC strains harboring the iss gene.
ymphocytic and lipid inﬁltration in the liver, whereas spleen
howed  areas of degeneration of the white and red pulp
Fig.  2B and D). Likewise, the liver of mice challenged with
train  41A showed marked vacuolization of hepatocytes and
ymphocytic  inﬁltration, whereas the spleen showed leuko-
yte  inﬁltration and white pulp without boundaries (data
ot  shown). Conversely, strain 4A showed hepatocytes, por-
al  space and lobular veins preserved with mild lymphocytic
nﬁltration in the liver. Also, the spleen was  morphologi-
ally preserved with capsule, and white pulp with central
rteriole besides red pulp (Fig. 2A and C). These histologi-
al  ﬁndings were  generally perceptible in all mice from each
nimal  group independently of the bacterial load in the
rgans.
iscussion
oultry-associated diseases caused by ExPEC cause massive
conomic losses in the food industry.18–20 However, the broad
se  of antimicrobials by poultry farmers in recent decades
as  led to the emergence of multidrug resistant strains in
any  parts of the globe.21–24 Additionally, among multidrugesistant E. coli from chickens and piglets in China, 97% har-
ored  the iss gene, suggesting this gene could also be used as
 multidrug resistance marker.22 In Brazil, a previous study 1 3;1  7(1):54–61  59
showed  that the rates of multidrug resistance among avian
E.  coli reached 77.5%.25 Regarding ExPEC strains harboring
the  iss gene, we conﬁrmed that the majority were  resis-
tant  to several antimicrobials beyond those authorized for
inclusion  in broiler feed. Although the number of strains
investigated was small, the levels of antimicrobial resistance
to  ampicillin, gentamicin, streptomycin, ciproﬂoxacin, chlor-
ramphenicol  and tetracycline were  very high in comparison
to  the levels found in a recent study carried out with 101 E. coli
strains  from broilers and layer hens with colibacillosis infec-
tions  in Bangladesh.26
Additionally, we have shown that a great number of avian
ExPEC  are probably -lactamase producing strains, since resis-
tance  to amoxycillin/clavulanic acid was  present in 70.4%
of  the isolates. Oteo et al.27 reported that resistance to
amoxicillin-clavulanic acid is increasing among E. coli from
human  origin in Spanish hospitals, affecting 5.1% of 9090
blood  isolates. Considering the food-chain, it is worrying that
the  only inhibitory drug against all avian ExPEC is carbapenem
imipinem, restricted to human use. Also of particular con-
cern  are the resistance of avian ExPEC to ﬂuoroquinoles such
as  enroﬂoxacin, which are similar to antibiotics being used
in  human medicine.28 For instance, the increasing resistance
of  E. coli strains to ciproﬂoxacin has been detected in several
international studies.29,30 Enroﬂoxacin has been withdrawal
from non-therapeutic use in the poultry industry in the United
States.31 In Europe, the drug cannot be used in the animals
from  which eggs are produced for human consumption.32
However, in this study the level of antimicrobial resistance
to  doxycycline, neomycin, enroﬂoxacin and oxytetracycline
reached alarming levels. Although we cannot conﬁrm that
Brazilian  farmers restrict their use of such antimicrobials to
treatment  regimens, it was clear that these drugs should no
longer  be used on Brazilian poultry farms.
Avian ExPEC strains have been genetically associated with
human  E. coli causing urinary infections.6 Additionally, E. coli
strains  of the EcoR group B2 related to human and animal
extraintestinal infections have been detected among APEC
strains  obtained from diseased and healthy chickens.33 In
spite  of the implications of avian ExPEC in carcasses of healthy
poultry  is unclear, a previous study in the UK showed that
samples  of imported chicken breasts were often positive for
E.  coli with CTX-M-2 genotype related to human infections
in  South America.34 Our data shows that resistance of avian
E.  coli to serum complement lyses in mammalian hosts was
not  directly related to the presence of the iss gene. This ﬁnding
suggests  that other genetic determinants among E. coli of avian
origin  must be related to human serum resistance. Addition-
ally,  multidrug-resistant ExPEC strains 41A and 2B were  often
more  resistant to goat and human serum complement, and
also  more  virulent to the experimentally infected mice than
strain  4A, which is sensitive to the majority of antimicrobials.
Previous studies have shown the correlation between
serum resistance and virulence of E. coli causing diseases
in  turkeys and chickens.35 Moreover, the characterization
a transferable hybrid plasmid pAPEC-O103-ColBM encod-described.11 Even though virulence and multidrug resistance
genes  are not uniformly distributed among conjugative plas-
mids,  the diversity of avian ExPEC with zoonotic potential to
60  b r a z j i n f e c t d i s . 2 0 1 3;1 7(1):54–61
Fig. 2 – Histological damage to laboratory animals after challenge with avian ExPEC. The slides of the liver (A and B) and
spleen (C and D) of Swiss mice challenged with strain 4A (A and C) and 2B (B and D) are shown. The full arrow (A and B)
indicates leukocyte inﬁltration whereas empty arrow shows degeneration of hepatocytes (B). The full star shows portal
space (A) and empty star shows degeneration of red besides white pulp (D). The asterisk shows the white pulp of the spleen
rin normal morphology (C).
cause human diseases can be more  frequent than perceived.
For  example, in the present study the risk for human health
was  particularly observed for strain 2B, obtained from poultry
carcasses  approved for human consumption. Thus, an early
diagnosis  procedure should be followed on poultry farms and
at  slaughterhouses to identify hazardous microorganisms in
asymptomatic poultry, and therefore eliminate carcasses that
are  not proper for human consumption. The data reinforce the
general  concern about the spread of multidrug-resistance and
virulence  genes between avian and human E. coli through the
food-chain.
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